Loading…
Based on limited metadata, this Warning Letter was issued to Homeocare Laboratories, Inc., a drug manufacturer, on June 22, 2020. While the specific violations are not detailed in the available metadata, the letter falls under FDA's drug regulation authority. Without access to the full letter text, the precise nature of the compliance issues cannot be determined, though the warning indicates serious regulatory concerns requiring the company's prompt attention and response.